WuXi NextCode, a genome sequencing analysis business with ties to China-based contract research organization WuXi PharmaTech, has raised $200 million in a Series C round of funding from a consortium led by the Ireland Strategic Investment Fund (ISIF).
Of the $200 million committed, the ISIF put down $70 million, with the rest coming from other participants include the company’s longtime existing shareholders Temasek, Yunfeng Capital and Sequoia Capital,...
Novo Tellus Capital Partners has invested S$12 million ($8.8 million) in Procurri, a Singapore-listed provider of IT services and data center equipment.
Australia’s Anacacia Capital has realized the final exit from its debut fund with the sale of its majority stake in workplace equipment provider RIS Safety to domestic investor Bricktop Group.
Bain Capital has acquired a majority interest in the data center construction and maintenance division of Shenzhen-listed NetScience Technology for RMB990 million ($147 million).
Shukun, a Chinese company that provides artificial intelligence (AI) technology used in the treatment of cardiovascular diseases, has raised RMB200 million ($29 million) in a Series B round led by China Creation Ventures.